Glypican-3 targeted delivery of 89Zr and 90Y as a theranostic radionuclide platform for hepatocellular carcinoma

Kevin P. Labadie(University of Washington), James O. Park(University of Washington Medical Center)
Scientific Reports
February 12, 2021
Cited by 21


Related Papers